DCM
HALO icon

Davidson Capital Management’s Halozyme HALO Stock Holding History

Davidson Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-56,223
Closed -$3.78M – 103
2025
Q4 		$3.78M Buy
56,223
+767
+1% +$51.6K 0.82% 30
2025
Q3 		$4.07M Sell
55,456
-575
-1% -$38.2K 0.91% 21
2025
Q2 		$2.91M Sell
56,031
-5,187
-8% -$295K 0.7% 51
2025
Q1 		$3.91M Buy
61,218
+4,579
+8% +$266K 1.06% 9
2024
Q4 		$2.71M Buy
56,639
+29,826
+111% +$1.53M 0.71% 48
2024
Q3 		$1.53M Buy
26,813
+26,623
+14,012% +$1.53M 0.44% 47
2024
Q2 		$9.95K Buy
190
+6
+3% +$263 ﹤0.01% 53
2024
Q1 		$7.49K Buy
+184
New +$6.9K ﹤0.01% 79

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Davidson Capital Management's HALO Position: Q1 2026 in Review

Davidson Capital Management sold out of Halozyme (HALO) in Q1 2026, closing a stake of 56,223 shares — an estimated $3.78M sold.

Davidson Capital Management first reported a position in HALO in Q1 2024 and held it in 8 quarters. The position peaked at $4.07M in Q3 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Davidson Capital Management reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • Davidson Capital Management sold 56,223 Halozyme shares in Q1 2026, an estimated $3.78M.
  • Davidson Capital Management first reported a position in Halozyme in Q1 2024 and held it in 8 quarters.
  • Davidson Capital Management's Halozyme position peaked at $4.07M in Q3 2025.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Davidson Capital Management's 13F filing for Q1 2026, filed 14 Apr 2026.